ANTI-HYPERGLYCEMIC EFFECT OF TERMINALIA CATAPPA FRUIT EXTRACT IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
Objective: To explore the anti-hyperglycemic effect of fruit extract of Terminalia catappa (Indian almond), a potential medicine from plant origin in a diabetic rat model.
Methods: Streptozotocin-induced chronic diabetic rat model was utilized in the study. Three doses of test drug, hydro-alcoholic fruit extract of Terminalia catappa in 20 mg/kg, 30 mg/kg and 40 mg/kg and a standard anti-diabetic drug, glibenclamide (10 mg/kg) was used. The study had a total of nine groups with eight animals in each group. Drugs were given orally every day for 12 w. Blood glucose, body weight and urine volume were measured weekly, glycosylated hemoglobin (HbA1c) was estimated at 12th week in all groups. Data for all parameters were analyzed using one-way ANOVA repeated measures followed by Mann-Whitney test.
Results: Hydro-alcoholic fruit extract of T. catappa significantly decreased blood glucose, urine volume and increased body weight in a dose-dependent manner in diabetic rats. At 12th week, blood glucose level in control, diabetic control, glibenclamide, T. catappa (40 mg/kg) group was 96.25Â±2.05 mg/dl, 599.75Â±0.25 mg/dl, 248.25Â±11.45 mg/dl, 115.00Â±3.78 mg/dl respectively. Effect of T. catappa in 30 mg/kg and 40 mg/kg dose was significantly more than glibenclamide. At 12th week, HbA1c level in control, diabetic control, glibenclamide, T. catappa (40 mg/kg) was 2.94Â±0.33 mmol/l, 4.94Â±0.49 mmol/l, 3.61Â±0.28 mmol/l, 3.21Â±0.27 mmol/l. Treatment with T. catappa 30 mg/kg, 40 mg/kg and glibenclamide brought back the level of HbA1c to normal levels. The addition of glibenclamide to T. catappa (40 mg/kg) did not produce any additional effect on blood glucose and HbA1c levels compared to the effect of T. catappa (40 mg/kg) in diabetic rats.
Conclusion: Terminalia catappa fruit extract exhibited a significant anti-hyperglycemic effect in diabetic rats and has a great potential to be used in diabetes.
2. Nair R, Chanda S. Antimicrobial activity of Terminalia catappa, Manilkara zapota and Piper betel Leaf Extract. Indian J Pharam Sci 2008;70 Suppl 3:390-3.
3. Venkatalakshmi P, Brindha P, Vellingiri V. In vitro antioxidant and anti-inflammatory studies on bark, wood and fruits of Terminalia catappa L. Int J Phytomed 2015;7 Suppl 3:246-53.
4. Annegowda HV, Mordi MN, Ramanathan S, Mansor SM. Analgesic and antioxidant properties of ethanolic extract of Terminalia catappa L. leaves. Int J Pharmacol 2010;6 Suppl 6:910-5.
5. Khan AA, Kumar V, Singh BK, Singh R. Evaluation of wound healing property of Terminalia catappa on excision wound models in Wistar rats. Drug Res 2014;64 Suppl 5:225-8.
6. Chyaua CC, Kob PT, Mau JL. Antioxidant properties of aqueous extracts from Terminalia catappa leaves. LWT 2006;39 Suppl 10:1099-108.
7. Gao J, Tang X, Dou H, Fan Y, Zhao X, Xu Q. Hepatoprotective activity of Terminalia catappa L. leaves and its two triterpenoids. J Pharm Pharmacol 2004;56:1449â€“55.
8. Pandya NB, Tigari P, Dupadahalli K, Kamurthy H, Nadendla RR. Antitumor and antioxidant status of Terminalia catappa against Ehrlich ascites carcinoma in Swiss albino mice. Indian J Pharmacol 2013;45 Suppl 5:464-9.
9. Satardekar KV, Deodhar MA. The anti-ageing ability of Terminalia species with special reference to hyaluronidase, elastase inhibition and collagen synthesis in vitro. Int J Pharmacogn Phytochem Res 2010;2:30-4.
10. Anand AV, Divya N, Kotti PP. An updated review of Terminalia catappa. Pharmacogn Rev 2015;9:93-8.
11. Koffi N, Yvette FNB, Noel ZG. Effect of aqueous extract of Terminalia catappa leaves on the glycaemia of rabbits. J Appl Pharm Sci 2011;1:59-64.
12. Malini P, Kanchana G, Rajadurai M. Antidiabetic efficacy of ellagic acid in streptozotocin induced diabetes mellitus in albino Wistar rats. Asian J Pharm Clin Res 2011;4 Suppl 3:124-8.
13. Wiejeratne S, Zaid AM, Shahidi F. Antioxidant polyphenols in almonds and its coproducts. J Agric Food Chem 2006;54 Suppl 2:312-8.
14. Gupta SK, Kumar B, Nag TC, Agarwal SS, Agarwal R, Agarwal P, et al. Curcumin prevents experimental diabetic retinopathy in rats through hypoglycaemic, antioxidant and anti-inflammatory mechanisms. J Ocul Pharmacol Ther 2011;27 Suppl 2:123-30.
15. Nagappa AN, Thakurdesai PA, Rao NV, Singh J. Antidiabetic activity of Terminalia catappa Linn fruits. J Ethnopharmacol 2003;88:45-50.
16. Mahimainathan L, Das F, Venkatesan B, Choudhury GG. Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN. Diabetes 2006;55:2115â€“25.
17. Rao NK, Nammi S. Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats. BMC Complementary Altern Med 2006;6:1-6.
18. Erejuwa OO, Sulaiman SA, Abdul Wahab MS, Kuttulebbai S, Salam N, Md Salleh MS, et al. Antioxidant protective effect of glibenclamide and metformin in combination with honey in pancreas of streptozotocin-induced diabetic rats. Int J Mol Sci 2010;11:2056-66.
19. Owolabi OJ, Omogbai EKI. Co-administration of glibenclamide and amlodipine induces resistance to hyperglycemic treatment in streptozotocin-induced adapted/non-adapted diabetic rats. Clin Exp Pharmacol 2011;1:1-7.
20. Ibegbulem CO, Eyong EU, Essien EU. Biochemical effects of drinking Terminalia catappa Linn. decoction in wistar rats. Afr J Biochem Res 2011;5:237-43.
21. Cabrera C, Artacho R, GimÃ©nez R. Beneficial effects of green tea-a review. J Am Coll Nutr 2006;25:79â€“99.
22. Iwai K, Kim MY, Onodera A, Matsue H. Alpha-glucosidase inhibitory and antihyperglycemic effects of polyphenols in the fruit of Viburnum dilatatum Thunb. Agric Food Chem 2006;54:4588â€“92.
23. Iwai K. Antidiabetic and antioxidant effects of polyphenols in brown alga Ecklonia stolonifera in genetically diabetic KK-A(y) mice. Plant Foods Hum Nutr 2008;63:163â€“9.
24. Ali H, Houghton PJ, Soumyanath A. Alpha-amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthusamarus. J Ethnopharmacol 2006;107:449-55.
25. Tadera K, Minami Y, Takamatsu K, Matsuoka T. Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. J Nutr Sci Vitaminol (Tokyo) 2006;52:149-53.
26. Salah EDR, Ma Q, Kandil ZA, El-Halawany AM. Triterpenes as uncompetitive inhibitors of Î±-glucosidase from flowers of PunicagranatumL. Nat Prod Res 2014;28:2191-4.
27. Salehi P, Asghari1 B, Esmaeili MA, Dehghan H, Ghazi I. Î±-Glucosidase and Î±-amylase inhibitory effect and antioxidant activity of ten plant extracts traditionally used in Iran for diabetes. J Med Plant Res 2013;7:257-66.
28. Sujith K, Darwin R, Roosewelt DRC. Antidiabetic activity of methanolic extract of Butea frondosa leaves with its possible mechanism of action. Asian J Pharm Clin Res 2011;4 Suppl 3:93-8.
29. Malini P, Kanchana G, Rajadurai M. Antidiabetic activity of ellagic acid in streptozotocin-induced diabetes mellitus in Albino Wistar rats. Asian J Pharm Clin Res 2011;4 Suppl 3:124-8.
30. Gandhi GR, Sasikumar P. Antidiabetic effect of Merremia emarginata Burm. F. in streptozotocin induced diabetic rats. Asian Pac J Trop Biomed 2012;2:281-6.
31. Mohan Y, Jesuthankaraj GN, Thangavelu NR. Antidiabetic and antioxidant properties of Triticum aestivum in Streptozotocin-induced diabetic rats. Adv Pharmcol Sci 2013:1-9. http://dx.doi.org/10.1155/2013/716073
32. Sampath V, Mani N. Novel approach of isolation of tannins from the fruit rind of Terminalia chebula and Punica granatum and its synergistic antidiabetic activity against streptozotocin induced diabetic rats. Int J Pharmacogn Phytochem Res 2015;7 Suppl 1:76-82.
33. Bahadoran Z, Mirmiran P, Azizi F. Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord 2013;12:43.
34. Andulla B, Varadacharyulu NCH. Antioxidant role of mulberry leaves in streptozotocin-diabetic rats. Clin Chim Acta 2003;338 Suppl 1-2:3-10.
35. Howarth FC, Jacobson M, Shafiullah M, Adeghate E. Long-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats. Exp Physiol 2005;90 Suppl 6:827-35.
36. Chen L, LaRocque LM, Efe O, Wang J, Sand JM, Klein JD. Effect of dapagliflozin on fluid and electrolyte balance in diabetic rats. Asian J Med Sci 2016;352 Suppl 5:517-23.
37. Tanwar RS, Sharma SB, Singh UR, Prabhu KM. Attenuation of renal dysfunction by anti-hyperglycemic compound isolated from fruit pulp of Eugenia jambolana in streptozotocin induced diabetic rats. Ind J Biochem Biophys 2010;47 Suppl 2:83â€“9.
38. Akbar DH, Hagras MM, Amin HA, Khorshid OA. Comparison between the effect of glibenclamide and captopril on experimentally induced diabetic nephropathy in rats. J Renin Angiotensin Aldosterone Syst 2013;14 Suppl 2:103-15.
39. Dubey VK, Patil CR, Kamble SM, Tidke PS, Patil KR, Maniya PJ, et al. Oleanolic acid prevents progression of streptozotocin induced diabetic nephropathy and protects renal microstructures in sprague dawley rats. J Pharmacol Pharmacother 2013;4 Suppl 1:47-52.
40. Diniz LRL, Portella VG, Cardoso FM, Souza MA, Caruso-Neves C, Cassali GD, et al. The effect of saponins from Ampelozizyphus amazonicus Ducke on the renal Na+pumpâ€™s activities and urinary excretion of natriuretic peptides. BMC Complementary Altern Med 2012;11 Suppl 12:1-7.